These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 348205)

  • 41. Effects of CGS 21680, a selective A2A adenosine receptor agonist, on cardiac output and vascular resistance in acute heart failure in the anaesthetized rat.
    Nekooeian AA; Tabrizchi R
    Br J Pharmacol; 1998 Apr; 123(8):1666-72. PubMed ID: 9605574
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical studies with a new cardiac glycoside proscillaridine A (Sandoscill)].
    Hansel J
    Med Klin; 1968 Jun; 63(23):919-22. PubMed ID: 4875202
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of captopril in heart failure complicating acute myocardial infarction and persistence of acute haemodynamic effects in chronic heart failure after 3 years of treatment.
    Mattioli G; Ricci S; Rigo R; Fusaro MT; Cappello C
    Postgrad Med J; 1986; 62 Suppl 1():164-6. PubMed ID: 3534855
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Heart rate behaviour and hemodynamics after oral therapy with ipratropium bromide in patients with sinus bradycardia (author's transl)].
    Kikis D; Esser H; Heinrich K
    Arzneimittelforschung; 1981; 31(10):1751-4. PubMed ID: 6459098
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The effect of cytostatic therapy on hemodynamics (author's transl)].
    Schwingshackl H; Schwingshackl A; Dienstl F; Knapp E; Gmeiner R
    Med Klin; 1974 Feb; 69(7):298-303. PubMed ID: 4522909
    [No Abstract]   [Full Text] [Related]  

  • 46. [Haemodynamic effects after application of nitroglycerin sublingually or as ointment in patients with left ventricular heart failure (author's transl)].
    Magometschnigg D; Bonelli J; Gassner A; Lenzhofer R; Kleinberger G; Pall H; Pichler M
    Wien Klin Wochenschr; 1980 Jan; 92(1):24-6. PubMed ID: 6769256
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Treatment of advanced heart failure with hydralazine and isosorbide dinitrate (author's transl)].
    Lanas F; Salvatici R; Opazo JA; Saavedra J; Iturriaga J
    Rev Med Chil; 1979 Oct; 107(10):926-30. PubMed ID: 550229
    [No Abstract]   [Full Text] [Related]  

  • 48. [Treatment of cardiac insufficiency with a new cardiac glycoside].
    Becker D
    Landarzt; 1965 Jul; 41(19):831-3. PubMed ID: 5320409
    [No Abstract]   [Full Text] [Related]  

  • 49. Evaluation of the therapeutic efficacy of L-carnitine in congestive heart failure.
    Ghidini O; Azzurro M; Vita G; Sartori G
    Int J Clin Pharmacol Ther Toxicol; 1988 Apr; 26(4):217-20. PubMed ID: 3403101
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinico-experimental characteristic of the new cardiac glycoside homphotin].
    Gatsura VV; Stupnitskiĭ AA
    Kardiologiia; 1968 Sep; 8(9):106-10. PubMed ID: 5728493
    [No Abstract]   [Full Text] [Related]  

  • 52. [Acedoxin treatment of patients with circulatory insufficiency].
    Savenkov PM; Martynov AI; Zadionchenko VS; Bart BIa
    Kardiologiia; 1968 Sep; 8(9):102-6. PubMed ID: 5728492
    [No Abstract]   [Full Text] [Related]  

  • 53. Haemodynamic studies with peruvoside in human congestive heart failure.
    Bhatia ML; Manchanda SC; Roy SB
    Br Med J; 1970 Sep; 3(5725):740-3. PubMed ID: 4919553
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical evaluation of Talusin in the treatment of cardiac insufficiency].
    Grujić M; Perinović M; Ljubojević S
    Med Arh; 1977; 31(3):171-5. PubMed ID: 333198
    [No Abstract]   [Full Text] [Related]  

  • 55. [Psychotropic agents and pathological ECG changes (author's transl)].
    Eckmann F; Schwalb H; Hanika R
    Pharmakopsychiatr Neuropsychopharmakol; 1975 Mar; 8(2):57-68. PubMed ID: 1233513
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of combined treatment with hydantoinal and cardiac glycosides on the dynamics of left ventricular contraction].
    Adamska-Dyniewska H
    Pol Arch Med Wewn; 1969 Jul; 43(1):985-9. PubMed ID: 4898864
    [No Abstract]   [Full Text] [Related]  

  • 57. [Does tolerance develop in cardiac glycoside therapy?].
    Werdan K; Erdmann E
    Dtsch Med Wochenschr; 1985 Nov; 110(44):1679-80. PubMed ID: 4053993
    [No Abstract]   [Full Text] [Related]  

  • 58. Observations on the effects of peruvoside.
    Raizada V; Padmavati S
    Indian J Med Res; 1971 Feb; 59(2):271-5. PubMed ID: 5579241
    [No Abstract]   [Full Text] [Related]  

  • 59. A comparative dose-effect study with cardiac glycosides assessing cardiac and extracardiac responses in normal subjects.
    Alken RG; Belz GG
    J Cardiovasc Pharmacol; 1984; 6(4):634-40. PubMed ID: 6206318
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Systolic time interval as a means of evaluating the cardiac functional capacity in patients with and without heart insufficiency].
    Kinner B; Krosse B; Sauer I
    Z Alternsforsch; 1983; 38(6):451-8. PubMed ID: 6659573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.